verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: gland pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler gland pharma limited
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Gland Pharma Limited

Identifiers & Regulatory

Product NDC 68083-447
Product ID 68083-447_97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214361
Listing Expiration 2026-12-31
Marketing Start 2020-10-15

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68083447
Hyphenated Format 68083-447

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0368083448059
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA214361 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (68083-447-25) / 2 mL in 1 VIAL
source: ndc

Packages (1)

68083-447-25 25 VIAL in 1 CARTON (68083-447-25) / 2 mL in 1 VIAL

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55", "openfda": {"upc": ["0368083448059"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["eb3c66f6-581f-422b-9ca2-9b877b323a33"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (68083-447-25)  / 2 mL in 1 VIAL", "package_ndc": "68083-447-25", "marketing_start_date": "20201015"}], "brand_name": "Verapamil hydrochloride", "product_id": "68083-447_97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68083-447", "generic_name": "Verapamil hydrochloride", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214361", "marketing_category": "ANDA", "marketing_start_date": "20201015", "listing_expiration_date": "20261231"}